Anatara Lifesciences Ltd (ANR.AX)
ASX · AUD · Healthcare · Biotechnology
A$0.008 (-11.11%) as of
Key statistics
- Market cap
- 2.53M
- Forward P/E
- 0.40
- EPS (TTM)
- -0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.0080 – 0.0170
- Beta
- 0.65
- Revenue (TTM)
- 318.4k
- Profit margin
- -293.10%
- Volume
- 345.62k
About Anatara Lifesciences Ltd
Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia. The company's products include irritable bowel syndrome; and Detach for the treatment of diarrhea in piglets. It also develops anti-obesity project, an oral complementary medication to assist weight reduction and control. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Adelaide, SA, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.